Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Devane

Showing results (91-100 of 129) with videos related to

Pageof 13
Sort By:
Clinical Pharmacology and Therapeutics|December 1, 1991
Pharmacokinetic and dynamic correlates of intravenous alprazolam challengeO T Osman, C L DeVane, D J Greenblatt, et al.
Pediatric Pharmacology (New York, N.Y.)|January 1, 1984
Concentrations of imipramine and its metabolites during enuresis therapyC L DeVane, R D Walker, W P Sawyer, et al.
Psychosomatic Medicine|August 19, 2000
Nefazodone in diabetic neuropathy: response and biologyP J Goodnick, K Breakstone, A Kumar, et al.
Life Sciences|January 1, 1989
Tissue distribution of cocaine in the pregnant ratC L DeVane, J W Simpkins, R L Miller, et al.
International Clinical Psychopharmacology|December 8, 2000
An assessment of selective serotonin reuptake inhibitor discontinuation symptoms with citalopramJ S Markowitz, C L DeVane, H L Liston, et al.
Clinical Pharmacology and Therapeutics|May 1, 1993
Evaluation of population pharmacokinetics in therapeutic trials. IV. Application to postmarketing surveillanceC L DeVane, T H Grasela, E J Antal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1995
Regional analysis of D2 dopamine receptors in Parkinson's disease using SPECT and iodine-123-iodobenzamideS E Nadeau, M W Couch, C L Devane, et al.
Therapeutic Drug Monitoring|June 1, 1997
Awareness of potential drug interactions may aid avoidanceC L DeVane, H S Gill, J S Markowitz, et al.
The American Journal of Psychiatry|June 1, 1997
Fluoroquinolone inhibition of clozapine metabolismJ S Markowitz, H S Gill, C L Devane, et al.
Life Sciences|January 1, 1991
Inhalational administration of cocaine in sheepD J Burchfield, R M Abrams, R L Miller, et al.
Pageof 13

Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
Clinical Pharmacology and Therapeutics|December 1, 1991
Pharmacokinetic and dynamic correlates of intravenous alprazolam challengeO T Osman, C L DeVane, D J Greenblatt, et al.
Pediatric Pharmacology (New York, N.Y.)|January 1, 1984
Concentrations of imipramine and its metabolites during enuresis therapyC L DeVane, R D Walker, W P Sawyer, et al.
Psychosomatic Medicine|August 19, 2000
Nefazodone in diabetic neuropathy: response and biologyP J Goodnick, K Breakstone, A Kumar, et al.
Life Sciences|January 1, 1989
Tissue distribution of cocaine in the pregnant ratC L DeVane, J W Simpkins, R L Miller, et al.
International Clinical Psychopharmacology|December 8, 2000
An assessment of selective serotonin reuptake inhibitor discontinuation symptoms with citalopramJ S Markowitz, C L DeVane, H L Liston, et al.
Clinical Pharmacology and Therapeutics|May 1, 1993
Evaluation of population pharmacokinetics in therapeutic trials. IV. Application to postmarketing surveillanceC L DeVane, T H Grasela, E J Antal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1995
Regional analysis of D2 dopamine receptors in Parkinson's disease using SPECT and iodine-123-iodobenzamideS E Nadeau, M W Couch, C L Devane, et al.
Therapeutic Drug Monitoring|June 1, 1997
Awareness of potential drug interactions may aid avoidanceC L DeVane, H S Gill, J S Markowitz, et al.
The American Journal of Psychiatry|June 1, 1997
Fluoroquinolone inhibition of clozapine metabolismJ S Markowitz, H S Gill, C L Devane, et al.
Life Sciences|January 1, 1991
Inhalational administration of cocaine in sheepD J Burchfield, R M Abrams, R L Miller, et al.
Pageof 13